Tetra-Q

TetraQ is an Australian contract research organization (CRO) that provides integrated preclinical and bioanalytical services to the global pharmaceutical and biotechnology industries. Established in 2005 as the commercial arm of the University of Queensland's Centre for Integrated Preclinical Drug Development, the company specializes in GLP-compliant toxicology, pharmacokinetics (PK), and bioanalysis. TetraQ's facilities support drug development from discovery through to clinical trials, offering services such as small molecule and protein concentration analysis, ADME studies, and safety pharmacology. In April 2021, the company was acquired by Agilex Biolabs, further expanding its capacity to support clinical trials in the Asia-Pacific region.